Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review.

Cindra Tri YuniarBhekti PratiwiArdika Fajrul IhsanBambang Tri LaksonoIffa RisfayantiAnnisa FathadinaYeonseon JeongEun Young Kim

Published in: Vaccines (2022)

The RCTs on the COVID-19 vaccine were less biased with good quality on reporting harm based on the modified CONSORT harm extension. However, study quality must be considered, especially for a balance of information between effectivity and safety.

Keyphrases

coronavirus disease
sars cov
adverse drug
quality improvement
emergency department
health information
social media
drug induced